These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

912 related items for PubMed ID: 15716832

  • 21. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
    Nagaki M, Iwai H, Naiki T, Ohnishi H, Muto Y, Moriwaki H.
    J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
    [Abstract] [Full Text] [Related]

  • 22. Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor alpha, interleukin-1beta, and interleukin-8 from peripheral blood monocytes via Fc gamma receptor IIA: a potential pathophysiologic mechanism for humoral anti-type II collagen immunity in arthritis.
    Mullazehi M, Mathsson L, Lampa J, Rönnelid J.
    Arthritis Rheum; 2006 Jun; 54(6):1759-71. PubMed ID: 16736518
    [Abstract] [Full Text] [Related]

  • 23. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis.
    Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ.
    Immunology; 1995 Apr; 84(4):536-42. PubMed ID: 7790026
    [Abstract] [Full Text] [Related]

  • 24. Analysis of the cytokine profiles of the synovial fluid in a normal temporomandibular joint: preliminary study.
    Kim YK, Kim SG, Kim BS, Lee JY, Yun PY, Bae JH, Oh JS, Ahn JM, Kim JS, Lee SY.
    J Craniomaxillofac Surg; 2012 Dec; 40(8):e337-41. PubMed ID: 22425498
    [Abstract] [Full Text] [Related]

  • 25. Increased levels of soluble cytokine receptors in the synovial fluid of temporomandibular joint disorders in relation to joint effusion on magnetic resonance images.
    Kaneyama K, Segami N, Yoshimura H, Honjo M, Demura N.
    J Oral Maxillofac Surg; 2010 May; 68(5):1088-93. PubMed ID: 20149511
    [Abstract] [Full Text] [Related]

  • 26. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA, Dayer JM, Feldman BM, Pruzanski W, Roux-Lombard P, Schneider R, Laxer RM, Silverman ED.
    J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
    [Abstract] [Full Text] [Related]

  • 27. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association.
    Knobler H, Zhornicky T, Sandler A, Haran N, Ashur Y, Schattner A.
    Am J Gastroenterol; 2003 Dec; 98(12):2751-6. PubMed ID: 14687828
    [Abstract] [Full Text] [Related]

  • 28. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.
    Turan B, Gallati H, Erdi H, Gürler A, Michel BA, Villiger PM.
    J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023
    [Abstract] [Full Text] [Related]

  • 29. [Expression of interleukin-1beta and tumor necrosis factor-alpha in the synovium and synovial fluid of patients with Kashin-Beck disease and osteoarthritis].
    Sun ZM, Ling M, Liu M, Zhang YG.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):5-8. PubMed ID: 19218098
    [Abstract] [Full Text] [Related]

  • 30. [The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions].
    Zhou J, Zhao Q, Yao H.
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):158-60. PubMed ID: 11778489
    [Abstract] [Full Text] [Related]

  • 31. Reduction of temporomandibular joint pain after treatment with a combination of methotrexate and infliximab is associated with changes in synovial fluid and plasma cytokines in rheumatoid arthritis.
    Kopp S, Alstergren P, Ernestam S, Nordahl S, Morin P, Bratt J.
    Cells Tissues Organs; 2005 Mar; 180(1):22-30. PubMed ID: 16088130
    [Abstract] [Full Text] [Related]

  • 32. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes.
    De Benedetti F, Pignatti P, Bernasconi S, Gerloni V, Matsushima K, Caporali R, Montecucco CM, Sozzani S, Fantini F, Martini A.
    J Rheumatol; 1999 Feb; 26(2):425-31. PubMed ID: 9972980
    [Abstract] [Full Text] [Related]

  • 33. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P, Kamińska J, Kowalska M, Ruka W, Steffen J.
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [Abstract] [Full Text] [Related]

  • 34. [Interleukin-6, tumor necrosis factor alpha and their soluble receptors in Bence-Jones nephropathy. Possible role in pathogenesis andthe importance in the determination of prognosis in renal insufficiency].
    Spicka I, Masek Z, Jirsa M, Zounar R, Procházka B, Merta M, Cieslar P, Tesar V, Klener P.
    Cas Lek Cesk; 1998 May 04; 137(9):267-70. PubMed ID: 9650354
    [Abstract] [Full Text] [Related]

  • 35. [Serum levels of solubule tumor necrosis factor (TNF) receptors in patients with pulmonary tuberculosis].
    Kawaguchi H, Ina Y, Ito S, Sato S, Sugiura Y, Tomita H, Ogisu N, Takada K, Yamamoto M, Morishita M, Yoshikawa K.
    Kekkaku; 1996 Mar 04; 71(3):259-65. PubMed ID: 8901228
    [Abstract] [Full Text] [Related]

  • 36. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells.
    Gallea-Robache S, Morand V, Millet S, Bruneau JM, Bhatnagar N, Chouaib S, Roman-Roman S.
    Cytokine; 1997 May 04; 9(5):340-6. PubMed ID: 9195133
    [Abstract] [Full Text] [Related]

  • 37. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
    Ribbens C, André B, Kaye O, Kaiser MJ, Bonnet V, de Groote D, Franchimont N, Malaise MG.
    Eur Cytokine Netw; 2000 Dec 04; 11(4):669-76. PubMed ID: 11125312
    [Abstract] [Full Text] [Related]

  • 38. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, Vischer T, Yazici H, Guerne PA.
    J Rheumatol; 1997 Feb 04; 24(2):303-8. PubMed ID: 9034987
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis.
    Corrigall VM, Bodman-Smith MD, Brunst M, Cornell H, Panayi GS.
    Arthritis Rheum; 2004 Apr 04; 50(4):1164-71. PubMed ID: 15077298
    [Abstract] [Full Text] [Related]

  • 40. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V, Jirsa M, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J.
    Med Sci Monit; 2002 Jan 04; 8(1):BR24-9. PubMed ID: 11782670
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.